PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Innovative Immunological Models Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, \'Fondazione Pascale\'-IRCCS, Naples, Italy.\', \'Laboratory Medicine Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, \'Fondazione Pascale\'-IRCCS, Naples, Italy.\', \'Ba.S.C.O. Unit, Cellular Manipulation and Immunogenetics, Oncology Department, AORN Santobono-Pausilipon, Naples, Italy.\', \'Molecular Biology and Viral Oncogenesis Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, \'Fondazione Pascale\'-IRCCS, Naples, Italy.\', \'Medical Direction, Istituto Nazionale per lo Studio e la Cura dei Tumori, \'Fondazione Pascale\'-IRCCS, Naples, Italy.\', \'Scientific Direction, Istituto Nazionale per lo Studio e la Cura dei Tumori, \'Fondazione Pascale\'-IRCCS, Naples, Italy.\', \'General Direction, Istituto Nazionale per lo Studio e la Cura dei Tumori, \'Fondazione Pascale\'-IRCCS, Naples, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.734689
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34386018
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34386018>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34386018>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all